苏州中药研究所

Suzhou Institute of Chinese Materia Medica is a specialized research and development organization focused on the modernization and industrialization of Traditional Chinese Medicine (TCM). Originally established in 1958 as a state-owned research entity, it now operates as a key subsidiary of the Leiyunshang Pharmaceutical Group. The institute specializes in the development of new TCM drug candidates, health supplements, and botanical-based cosmetics, bridging classical herbal knowledge with modern pharmacological standards. It provides essential technical services including quality standard research, pharmacological and toxicological testing, and pilot-scale manufacturing for the broader pharmaceutical industry in China. The institute is instrumental in maintaining the scientific competitiveness of the Leiyunshang brand through continuous innovation in extraction and formulation technologies.